ESR1 and breast cancer: Since it has previously demonstrated that antagonizing ER activity by prolonged tamoxifen treatment stimulates adhesion dependent p130Cas tyrosine phosphorylation in breast cancer cell lines [29], we checked whether treatment with ICI 182, 780 and AG1470 affects p130Cas phosphorylation status.